{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:30:07Z","timestamp":1707525007352},"reference-count":9,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,1,23]]},"DOI":"10.7759\/cureus.34121","type":"journal-article","created":{"date-parts":[[2023,1,24]],"date-time":"2023-01-24T06:36:01Z","timestamp":1674542161000},"source":"Crossref","is-referenced-by-count":0,"title":["Statin-Induced Anti-3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase (Anti-HMGCR) Myopathy"],"prefix":"10.7759","author":[{"given":"Fatima","family":"Ghazal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle","family":"Zur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaron","family":"Silver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3233\/JND-170282","article-title":"Anti-HMGCR myopathy","volume":"5","author":"Mohassel P","year":"2018","unstructured":"Mohassel P, Mammen AL. Anti-HMGCR myopathy. J Neuromuscul Dis. 2018, 5:11-20. 10.3233\/JND-170282","journal-title":"J Neuromuscul Dis"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2017.09.016","article-title":"224th ENMC international workshop:: clinico-sero-pathological classification of immune-mediated necrotizing myopathies Zandvoort, The Netherlands, 14-16 October 2016","volume":"28","author":"Allenbach Y","year":"2018","unstructured":"Allenbach Y, Mammen AL, Benveniste O, Stenzel W. 224th ENMC international workshop:: clinico-sero-pathological classification of immune-mediated necrotizing myopathies Zandvoort, The Netherlands, 14-16 October 2016. Neuromuscul Disord. 2018, 28:87-99. 10.1016\/j.nmd.2017.09.016","journal-title":"Neuromuscul Disord"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/art.40063","article-title":"Editorial: a new classification of adult autoimmune myositis","volume":"69","author":"Sen\u00e9cal JL","year":"2017","unstructured":"Sen\u00e9cal JL, Raynauld JP, Troyanov Y. Editorial: a new classification of adult autoimmune myositis. Arthritis Rheumatol. 2017, 69:878-84. 10.1002\/art.40063","journal-title":"Arthritis Rheumatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/art.27572","article-title":"A novel autoantibody recognizing 200-kd and 100-kd proteins is associated with an immune-mediated necrotizing myopathy","volume":"62","author":"Christopher-Stine L","year":"2010","unstructured":"Christopher-Stine L, Casciola-Rosen LA, Hong G, Chung T, Corse AM, Mammen AL. A novel autoantibody recognizing 200-kd and 100-kd proteins is associated with an immune-mediated necrotizing myopathy. Arthritis Rheum. 2010, 62:2757-66. 10.1002\/art.27572","journal-title":"Arthritis Rheum"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/art.30344","article-title":"Correlation of anti-signal recognition particle autoantibody levels with creatine kinase activity in patients with necrotizing myopathy","volume":"63","author":"Benveniste O","year":"2011","unstructured":"Benveniste O, Drouot L, Jouen F, et al.. Correlation of anti-signal recognition particle autoantibody levels with creatine kinase activity in patients with necrotizing myopathy. Arthritis Rheum. 2011, 63:1961-71. 10.1002\/art.30344","journal-title":"Arthritis Rheum"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.171495","article-title":"Rituximab in the treatment of refractory anti-HMGCR immune-mediated necrotizing myopathy","volume":"46","author":"Landon-Cardinal O","year":"2019","unstructured":"Landon-Cardinal O, Allenbach Y, Soulages A, et al.. Rituximab in the treatment of refractory anti-HMGCR immune-mediated necrotizing myopathy. J Rheumatol. 2019, 46:623-7. 10.3899\/jrheum.171495","journal-title":"J Rheumatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0000000000000832","article-title":"Anti-HMGCR myopathy: clinical and histopathological features, and prognosis","volume":"33","author":"Kurashige T","year":"2021","unstructured":"Kurashige T. Anti-HMGCR myopathy: clinical and histopathological features, and prognosis. Curr Opin Rheumatol. 2021, 33:554-62. 10.1097\/BOR.0000000000000832","journal-title":"Curr Opin Rheumatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kew470","article-title":"More severe disease and slower recovery in younger patients with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase-associated autoimmune myopathy","volume":"56","author":"Tiniakou E","year":"2017","unstructured":"Tiniakou E, Pinal-Fernandez I, Lloyd TE, et al.. More severe disease and slower recovery in younger patients with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase-associated autoimmune myopathy. Rheumatology (Oxford). 2017, 56:787-94. 10.1093\/rheumatology\/kew470","journal-title":"Rheumatology (Oxford)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1080\/03009742.2019.1672782","article-title":"Anti-hydroxy-3-methylglutaryl-coenzyme A reductase (anti-HMGCR) antibody in necrotizing myopathy: treatment outcomes, cancer risk, and role of autoantibody level","volume":"49","author":"Aggarwal R","year":"2020","unstructured":"Aggarwal R, Moghadam-Kia S, Lacomis D, et al.. Anti-hydroxy-3-methylglutaryl-coenzyme A reductase (anti-HMGCR) antibody in necrotizing myopathy: treatment outcomes, cancer risk, and role of autoantibody level. Scand J Rheumatol. 2020, 49:405-11. 10.1080\/03009742.2019.1672782","journal-title":"Scand J Rheumatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/127490-statin-induced-anti-3-hydroxy-3-methylglutaryl-coenzyme-a-reductase-anti-hmgcr-myopathy","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:57:52Z","timestamp":1707508672000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/127490-statin-induced-anti-3-hydroxy-3-methylglutaryl-coenzyme-a-reductase-anti-hmgcr-myopathy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,23]]},"references-count":9,"URL":"https:\/\/doi.org\/10.7759\/cureus.34121","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1,23]]}}}